 |
5 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- AZD5658 / AstraZeneca
Enrollment change: To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes (clinicaltrials.gov) - Jan 31, 2012
P1, N=24, Completed, Sponsor: AstraZeneca
N=48 --> 24